-
You may have heard anecdotes from teen patients or read articles in the popular press, but now clinicians have solid data confirming that oral sex is becoming more commonplace among adolescents.
-
Have you taken a look at your paycheck lately? Most family planning providers say their salaries have recorded a slight increase in 2005, according to the results of the annual Contraceptive Technology Update salary survey.
-
Clinicians who are weighing use of digital vs. film mammography for detection of breast cancer may be able to make more informed choices now that results of a large national study have been compiled.
-
The young woman waiting in your exam room has indicated she would like a method of long-term contraception, but she says she has experienced estrogen-related side effects from previous pill use. What options can you offer her?
-
Rewind to November 2004. Netherlands-based Akzo Nobels pharmaceutical business Organon announces that the Food and Drug Administration (FDA) has granted approvable status for its etonogestrel subdermal contraceptive implant Implanon. Fast forward to today. Do you see the method added to the U.S. contraceptive mix?
-
In reviewing patient files from the last month, how many chlamydia tests were performed at your facility, and how many yielded positive results? If your clinic is seeing an increase in screens, as well as a higher incidence of infection, you are part of a larger nationwide trend.
-
The woman sitting in front of you tells you that she has been experiencing abdominal pain, abdominal swelling, gastrointestinal symptoms, and pelvic pain. What is your next move?
-
Your next patient is a young mother who just gave birth to a healthy infant eight weeks ago. She is breast-feeding her baby and wants to use a safe method of contraception that will not affect her milk supply. What option will she choose?
-
Intrauterine contraception may see a wider audience in the United States with a major pharmaceutical companys acquisition of the manufacturer of the ParaGard TCu 380A intrauterine device (IUD).
-
The long road toward a woman-controlled form of prevention against HIV infection may have just gotten a little shorter with the recent agreement by two major drug companies to license promising compounds at no charge for microbicide development to a nonprofit group.